“推进骨组织工程和3D生物打印的植物源化合物和材料：传统医学方面和当前观点”的勘误表

IF 3.1 3区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Journal of Tissue Engineering and Regenerative Medicine Pub Date : 2025-05-18 DOI:10.1155/term/9785638

{"title":"“推进骨组织工程和3D生物打印的植物源化合物和材料：传统医学方面和当前观点”的勘误表","authors":"","doi":"10.1155/term/9785638","DOIUrl":null,"url":null,"abstract":"J. Heinämäki, O. Koshovyi, I. Botsula, et al., “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” Journal of Tissue Engineering and Regenerative Medicine 2025, no. 6 (2025): 1–23, https://doi.org/10.1155/term/2812191.In the article titled “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” there was an error in the Funding section, where the MSCA4Ukraine project is not acknowledged. The corrected section appears below.This work was supported by the Estonian Research Council (ERC) grant (PRG1903) and by the European Union in the MSCA4Ukraine project “Design and development of 3D-printed medicines for bioactive materials of Ukrainian and Estonian medicinal plants origin” (1232466).We apologize for this error.","PeriodicalId":202,"journal":{"name":"Journal of Tissue Engineering and Regenerative Medicine","volume":"2025 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/term/9785638","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives”\",\"authors\":\"\",\"doi\":\"10.1155/term/9785638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"J. Heinämäki, O. Koshovyi, I. Botsula, et al., “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” Journal of Tissue Engineering and Regenerative Medicine 2025, no. 6 (2025): 1–23, https://doi.org/10.1155/term/2812191.In the article titled “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” there was an error in the Funding section, where the MSCA4Ukraine project is not acknowledged. The corrected section appears below.This work was supported by the Estonian Research Council (ERC) grant (PRG1903) and by the European Union in the MSCA4Ukraine project “Design and development of 3D-printed medicines for bioactive materials of Ukrainian and Estonian medicinal plants origin” (1232466).We apologize for this error.\",\"PeriodicalId\":202,\"journal\":{\"name\":\"Journal of Tissue Engineering and Regenerative Medicine\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/term/9785638\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Tissue Engineering and Regenerative Medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/term/9785638\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tissue Engineering and Regenerative Medicine","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/term/9785638","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

J. Heinämäki， O. Koshovyi， I. Botsula，等，“推进骨组织工程和3D生物打印的植物来源化合物和材料：传统医学方面和当前观点，”组织工程与再生医学杂志2025，第2期。6 (2025): 1-23, https://doi.org/10.1155/term/2812191.In题为“推进骨组织工程和3D生物打印的植物源化合物和材料：传统医学方面和当前观点”的文章，在资助部分有一个错误，其中没有承认MSCA4Ukraine项目。更正后的部分如下所示。这项工作得到了爱沙尼亚研究委员会（ERC）拨款（PRG1903）和欧盟MSCA4Ukraine项目“乌克兰和爱沙尼亚药用植物生物活性材料3d打印药物的设计和开发”（1232466）的支持。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives”

J. Heinämäki, O. Koshovyi, I. Botsula, et al., “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” Journal of Tissue Engineering and Regenerative Medicine 2025, no. 6 (2025): 1–23, https://doi.org/10.1155/term/2812191.

In the article titled “Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives,” there was an error in the Funding section, where the MSCA4Ukraine project is not acknowledged. The corrected section appears below.

This work was supported by the Estonian Research Council (ERC) grant (PRG1903) and by the European Union in the MSCA4Ukraine project “Design and development of 3D-printed medicines for bioactive materials of Ukrainian and Estonian medicinal plants origin” (1232466).

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Tissue Engineering and Regenerative Medicine 生物-工程：生物医学

CiteScore

7.50

自引率

3.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs. The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.